Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-097067
Filing Date
2024-09-04
Accepted
2024-09-04 21:59:14
Documents
1
Period of Report
2024-08-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2423415-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2423415-3_4seq1.xml 4 6527
  Complete submission text file 0001104659-24-097067.txt   8108
Mailing Address C/O AEON BIOPHARMA, INC. 4040 MACARTHUR BLVD., SUITE 260 NEWPOER BEACH CA 92660
Business Address
Forth Marc (Reporting) CIK: 0001816988 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40021 | Film No.: 241279730

Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Issuer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)